Name |
Substance |
Suspension Period |
Notes |
Atalelech Asfaw |
Ephedrine |
5-18-14 to 5-17-16 |
|
Cody Bidlow |
Growth hormone releasing factors (GHRFs) |
08-09-16 to 08-08-20 |
|
Mark Block |
Various Anti-Doping Rule Violations |
1-1-09 to 1-1-19 |
|
Dr. Jeffrey Brown |
Various Anti-Doping Rule Violations |
09-30-19 to 09-29-23 |
|
Kayla Bushey |
Ostarine and Arimistane |
12-19-16 to 12-19-18 |
|
Andrew Carnes |
Synthetic Erythropoietin (EPO) |
10-25-13 to 10-24-15 |
|
Chris Carter |
Ostarine |
03-13-17 to 12-13-17 |
|
Thomas Cawley |
Growth hormone (GH) releasing factors (GHRFs), GH-releasing hormone (GHRH) analogs, and synthetic growth factors |
06-16-16 to 06-15-20 |
|
Marcus Clavelle |
Methandienone |
08-23-02 to 08-23-04 |
|
Michelle Collins |
Conspiracy and cover-up |
12-09-04 to 07-17-08 |
Reinstatement Pending |
Jessica Cosby-Toruga |
Extrogenous Androgenic Anabolic Steroids |
09-12-16 to 09-11-22 |
|
Brian Coushay |
Amphetamine |
09-09-15 to 09-08-17 |
|
Crystal Cox |
Conspiracy and cover-up |
01-26-10 to 01-25-14 |
|
Shawn Crawford |
Three Whereabouts Failures in 18 month period |
04-17-2013 to 04-16-2015 |
|
Royce Dates |
Ostarine, and tampering, administration and complicity |
11-08-17 to 11-08-21 |
|
Todd Davis |
Refusal to Test |
10-02-19 to 10-01-23 |
|
Walter Davis |
Three Whereabouts Failures in an 18 month period |
04-16-14 to 04-15-15 |
|
Matthew DiBuono |
Adverse CIR |
08-17-11 to 01-14-16 |
|
Reginald Dixon |
Three Whereabouts Failures in an 18-month period |
05-30-14 to 5-29-15 |
|
Trey Downing |
Refusal to Test |
5-29-2013 to 11-28-2014 |
|
Jon Drummond |
Possesion, trafficking, and administering |
12-17-2014 to 12-16-2022 |
|
Byron Duhon |
Refusal to Test |
10-21-11 to 10-2-20-13 |
|
Debbie Dunn |
Anabolic Androgenic Steroids |
08-01-12 to 08-01-14 |
|
Marquise Goodwin |
Three Whereabouts Failures in 12 month period |
04-01-17 to 04-01-18 |
|
Alvin Harrison |
Undetectable Steroids and Erythropoietin (EPO) |
10-18-04 to 10-18-08 |
|
Calvin Harrison |
Modafinil |
07-26-04 to 07-26-06 |
|
Scott Henning |
Methandienone |
05-02-02 to 05-02-04 |
|
Christian Hesch |
Erythropoietin (EPO) |
09-26-12 to 03- 26-14 |
|
Jeremy Hicks |
Three Whereabouts Failures in an 18 month period |
06-05-14 to 06-04-15 |
|
Cottrel J. Hunter |
Nandrolone Metabolites |
03-08-01 to 03-08-03 |
Retired 03-08-01 |
Kathy Jager |
Adverse CIR |
9-26-11 to 9-25-13 |
|
Regina Jacobs |
Tetrahydrogestrinone |
07-17-04 to 07-16-08 |
Retired 08-02-04 |
Mark Jelks |
Three Whereabouts Failures in 18 Month Period |
08-31-10 to 08-23-12 |
|
Marion Jones |
Admitted having used a prohibited substance |
10-08-07 to 10-07-09 |
Retired 11-09-07 |
Lisa Knoblich |
Failure to provide sample |
04-14-98 to 04-14-00 |
|
Trell Kimmons |
1,3-dimethylbutylamine |
04-14-16 to 04-13-18 |
|
Tod Long |
Nandrolone |
12-20-01 to 12-20-02 |
|
Chris Lukezic |
Failure to provide sample |
08-31-10 to 08-31-12 |
Retired 04-29-10 |
John McEwen |
Tetrahydrogestrinone and Modafinil |
04-19-04 to 04-19-06 |
|
Timothy Montgomery |
Admitted having used a prohibited substance |
06-06-05 to 06-06-07 |
|
Darien Moore |
Methandienone metabolites epimetendiol, 17-epimethandienone and 17β-hydroxymethyl-17α -methy-18-norandrost-1, 4,13-trien-3-one |
03-04-17 to 03-03-21 |
|
Nicholas Mossberg |
Growth hormone releasing factors (GHRFs) |
04-25-16 to 04-24-20 |
|
Cliff Nielson |
Growth hormone (GH) releasing factors (GHRFs), GH-Releasing Hormone(GHRH) analog modified GFR (1-29), GH Secretagogue (GHS) impamorelin, and GH Releasing Peptide (GHRP) GHRP-2 |
04-26-17 to 04-25-21 |
|
Imani Oliver |
Ostarine |
07-07-16 to 07-06-17 |
|
Liz Palmer |
17β-hydroxymethyl-17α-methyl-18-norandrost-1,4,13-trien-3-one |
03-05-16 to 09-04-19 |
|
Vikas Patel |
Ostarine |
01-27-17 to 01-27-21 |
|
Demi Payne |
Drostanolone |
03-31-16 to 03-30-20 |
|
Greg Pizza |
Exogenous anabolic steroid |
09-11-15 to 05-10-17 |
|
Tori Polk |
Peptide hormones, growth factors, related substances and mimetics |
04-25-16 to 04-25-18 |
|
Quintaveon Poole |
Methylhexaneamine |
07-27-14 to 01-26-15 |
|
Mitchell Pope |
Boldenone Metabolite |
01-15-09 to 01-15-11 |
|
Brianna Rollins |
Three Whereabouts Failures in 12-month period |
12-19-16 to 12-18-17 |
|
Serene Ross |
Hydrochlorothiazide and Triamterene |
07-27-06 to 07-27-08 |
Retired 01-26-06 |
Alberto Salazar |
Various Anti-Doping Rule Violations |
09-30-19 to 09-29-23 |
|
Jonathan Sanford |
Ostarine |
06-02-17 to 06-02-18 |
|
Stephen Craig Shumaker |
Adverse CIR |
9-9-11 to 9-8-13 |
|
Wallace Spearmon |
Methylprednisolone |
8-27-14 to 11-26-14 |
|
Eric Thompson |
Benzoylecgonine |
07-18-07 to 07-18-08 |
|
Kevin Toth |
Tetrahydrogestrinone |
05-03-04 to 05-03-06 |
Retired 02-17-04 |
Mohamed Trafeh |
Repeated use and possession oferythropoietin (EPO) and evading sample collection |
12-02-14 to 12-01-18 |
|
Jordan Vaden |
Stanozolol |
02-04-09 to 02-04-11 |
|
Atlanta Westbrook |
Ostarine, and tampering and complicity |
10-31-17 to 10-31-21 |
|
Kelli White |
Undetectable Steroids and Erythropoietin (EPO) |
05-17-04 to 05-16-06 |
Retired 08-03-06 |
Kenna Wolter |
Ostarine and methylstenbolone |
12-13-16 to 12-13-18 |
|
Jason Young |
Growth hormone releasing factors (GHRFs) |
11-17-16 to 11-16-20 |
|